BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1312194)

  • 21. The mechanisms and significance of the coupled release of endothelium-derived relaxing factor (EDRF) and prostacyclin (PGI2) from endothelial cells.
    Hyslop S; de Nucci G
    Wien Klin Wochenschr; 1991; 103(14):422-34. PubMed ID: 1926869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin II-induced constrictions are masked by bovine retinal vessels.
    Kulkarni PS; Hamid H; Barati M; Butulija D
    Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):721-8. PubMed ID: 10067976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions between nitric oxide and prostacyclin in myocardial ischemia and endothelial cell cultures.
    Schrör K; Woditsch I; Strobach H; Schröder H
    Basic Res Cardiol; 1991; 86 Suppl 2():117-25. PubMed ID: 1659372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Release of endothelium-derived relaxing factor from pig cultured aortic endothelial cells, as assessed by changes in endothelial cell cyclic GMP content, is inhibited by a phorbol ester.
    Smith JA; Lang D
    Br J Pharmacol; 1990 Mar; 99(3):565-71. PubMed ID: 1691949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EDRF and nitric oxide production in cultured endothelial cells: direct inhibition by E. coli endotoxin.
    Myers PR; Wright TF; Tanner MA; Adams HR
    Am J Physiol; 1992 Mar; 262(3 Pt 2):H710-8. PubMed ID: 1558180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelium-derived relaxing factor (EDRF) from cultured and fresh endothelial cells.
    Gryglewski RJ; Trybulec M; Radziszewski W; Swierkosz T; Dudek R; Zembowicz A
    Biomed Biochim Acta; 1988; 47(10-11):S61-6. PubMed ID: 2470361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioassay of prostacyclin and endothelium-derived relaxing factor (EDRF) from porcine aortic endothelial cells.
    Gryglewski RJ; Moncada S; Palmer RM
    Br J Pharmacol; 1986 Apr; 87(4):685-94. PubMed ID: 3085757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alkaline buffers release EDRF from bovine cultured aortic endothelial cells.
    Mitchell JA; de Nucci G; Warner TD; Vane JR
    Br J Pharmacol; 1991 Jun; 103(2):1295-302. PubMed ID: 1884092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nitric oxide but not prostacyclin is an autocrine endothelial mediator.
    Schröder H; Strobach H; Schrör K
    Biochem Pharmacol; 1992 Feb; 43(3):533-7. PubMed ID: 1371684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endothelium-derived bradykinin: implications for angiotensin-converting enzyme-inhibitor therapy.
    Busse R; Fleming I; Hecker M
    J Cardiovasc Pharmacol; 1993; 22 Suppl 5():S31-6. PubMed ID: 7508049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic exposure of cultured endothelial cells to eicosapentaenoic acid potentiates the release of endothelium-derived relaxing factor(s).
    Boulanger C; Schini VB; Hendrickson H; Vanhoutte PM
    Br J Pharmacol; 1990 Jan; 99(1):176-80. PubMed ID: 2158833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different patterns of release of endothelium-derived relaxing factor and prostacyclin.
    Mitchell JA; de Nucci G; Warner TD; Vane JR
    Br J Pharmacol; 1992 Feb; 105(2):485-9. PubMed ID: 1373103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methylene blue but not changes in cyclic GMP inhibits resting and bradykinin-stimulated production of prostacyclin by pig aortic endothelial cells.
    Martin W; Drazan KM; Newby AC
    Br J Pharmacol; 1989 May; 97(1):51-6. PubMed ID: 2541859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nitric oxide but not prostacyclin has an autocrine function in porcine aortic endothelial cells.
    Schröder H; Machunsky C; Strobach H; Schrör K
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():671-4. PubMed ID: 1825396
    [No Abstract]   [Full Text] [Related]  

  • 35. Probing of the canine mammary artery damages endothelium and impairs vasodilation resulting from prostacyclin and endothelium-derived relaxing factor.
    Johns RA; Peach MJ; Flanagan T; Kron IL
    J Thorac Cardiovasc Surg; 1989 Feb; 97(2):252-8. PubMed ID: 2492624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide.
    Radomski MW; Palmer RM; Moncada S
    Br J Pharmacol; 1987 Nov; 92(3):639-46. PubMed ID: 3322462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelium-derived relaxing factor and atriopeptin II elevate cyclic GMP levels in pig aortic endothelial cells.
    Martin W; White DG; Henderson AH
    Br J Pharmacol; 1988 Jan; 93(1):229-39. PubMed ID: 2894877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytokine-mediated induction of cyclo-oxygenase-2 by activation of tyrosine kinase in bovine endothelial cells stimulated by bacterial lipopolysaccharide.
    Akarasereenont P; Bakhle YS; Thiemermann C; Vane JR
    Br J Pharmacol; 1995 Jun; 115(3):401-8. PubMed ID: 7582449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancement of cytosolic calcium, prostacyclin and nitric oxide by bradykinin and the ACE inhibitor ramiprilat in porcine brain capillary endothelial cells.
    Wiemer G; Popp R; Schölkens BA; Gögelein H
    Brain Res; 1994 Feb; 638(1-2):261-6. PubMed ID: 7515323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential sensitivities of the prostacyclin and nitric oxide biosynthetic pathways to cytosolic calcium in bovine aortic endothelial cells.
    Parsaee H; McEwan JR; Joseph S; MacDermot J
    Br J Pharmacol; 1992 Dec; 107(4):1013-9. PubMed ID: 1361398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.